Intratumorally specific microbial-derived lipopolysaccharide contributes to non-small cell lung cancer progression

abundance, and LPS content had greater diagnostic validity in predicting the probability of NSCLC, and the detection of these factors in blood has potential for using the non-invasive diagnosis of NSCLC. Overall, this study revealed the mechanism by which LPS from specific bacteria in TME promoted tumor development, providing new strategies for NSCLC treatment and diagnosis from a microbial perspective.